参考文献/References:
[1] Thomas H,Diamond J,Vieco A,et al. Global atlas of cardiovascular disease 2000-2016:the path to prevention and control[J]. Glob Heart,2018,13 (3):143-163.
[2] Jang AY,Ryu J,Oh PC,et al. Feasibility and applicability of wireless handheld ultrasound measurement of carotid intima-media thickness in patients with cardiac symptoms[J]. Yonsei Med J,2020,61(2):129-136.
[3] Kokubo Y,Watanabe M,Higashiyama A,et al. Impact of intima-media thickness progression in the common carotid arteries on the risk of incident cardiovascular disease in the Suita study[J]. J Am Heart Assoc,2018,7(11):e007720.
[4] Guaricci AI,Lorenzoni V,Guglielmo M,et al. Prognostic relevance of subclinical coronary and carotid atherosclerosis in a diabetic and nondiabetic asymptomatic population[J]. Clin Cardiol,2018,41(6):769-777.
[5] 程晓艺,寇秀玲,黄明刚,等. 颈动脉斑块与冠状动脉粥样硬化相关性影像学分析[J]. 心血管病学进展,2019,40(6):960-966.[6] Inaba Y,Chen JA,Bergmann SR. Carotid plaque,compared with carotid intima-media thickness,more accurately predicts coronary artery disease events:a meta-analysis[J]. Atherosclerosis,2012,220(1):128-133.
[7] Jiang D,Wang Y,Chang G,et al. DNA hydroxymethylation combined with carotid plaques as a novel biomarker for coronary atherosclerosis[J]. Aging(Albany NY),2019,11(10):3170-3181.
[8] Jeevarethinam A,Venuraju S,Dumo A,et al. Usefulness of carotid plaques as predictors of obstructive coronary artery disease and cardiovascular events in asymptomatic individuals with diabetes mellitus[J]. Am J Cardiol,2018,121(8):910-916.
[9] Pasterkamp G,Schoneveld AH,Hillen B,et al. Is plaque formation in the common carotid artery representative for plaque formation and luminal stenosis in other atherosclerotic peripheral arteries? a post mortem study[J]. Atherosclerosis,1998,137(1):205-210.
[10] Fernandez-Friera L,Penalvo JL,Fernandez-Ortiz A,et al. Prevalence,vascular distribution,and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort:the PESA(Progression of Early Subclinical Atherosclerosis) Study[J]. Circulation,2015,131(24):2104-2113.
[11] Kirhmajer MV,Banfic L,Vojkovic M,et al. Correlation of femoral intima-media thickness and the severity of coronary artery disease[J]. Angiology,2011,62(2):134-139.
[12] Bryniarski KL,Tokarek T,Bryk T,et al. Intima-media thickness and ankle-brachial index are correlated with the extent of coronary artery disease measured by the SYNTAX score[J]. Postepy Kardiol Interwencyjnej,2018,14(1):52-58.
[13] Hoehmann CL,Futterman B,Beatty BL. Peripheral arteries may be reliable indicators of coronary vascular disease[J]. Anat Rec(Hoboken),2017,300(7):1230-1239.
[14] Noflatscher M,Schreinlechner M,Sommer P,et al. Influence of traditional cardiovascular risk factors on carotid and femoral atherosclerotic plaque volume as measured by three-dimensional ultrasound[J]. J Clin Med,2018,8(1):32.
[15] Chen HC,Wang WT,Hsi CN,et al. Abdominal aortic calcification score can predict future coronary artery disease in hemodialysis patients:a 5-year prospective cohort study[J]. BMC Nephrol,2018,19(1):313.
[16] Li W,Luo S,Luo J,et al. Association between abdominal aortic plaque and coronary artery disease[J]. Clin Interv Aging,2016,11:683-688.
[17] Criqui MH,Denenberg JO,McClelland RL,et al. Abdominal aortic calcium,coronary artery calcium,and cardiovascular morbidity and mortality in the multi-ethnic study of atherosclerosis[J]. Arterioscler Thromb Vasc Biol,2014,34(7):1574-1579.
[18] Icen YK,Koc AS,Sumbul HE. Coronary artery disease severity is associated with abdominal aortic intima-media thickness in patients with non-ST-segment elevation myocardial infarction[J]. Angiology,2019,70(6):561-566.
[19] Gao Y,Wang YC,Lu CQ,et al. Correlations between the abdominal fat-related parameters and severity of coronary artery disease assessed by computed tomography[J]. Quant Imaging Med Surg,2018,8(6):579-587.
[20] Onuma OK,Pencina K,Qazi S,et al. Relation of risk factors and abdominal aortic calcium to progression of coronary artery calcium(from the Framingham Heart Study)[J]. Am J Cardiol,2017,119(10):1584-1589.
[21] Suh B,Song YS,Shin DW,et al. Incidentally detected atherosclerosis in the abdominal aorta or its major branches on computed tomography is highly associated with coronary heart disease in asymptomatic adults[J]. J Cardiovasc Comput Tomogr,2018,12(4):305-311.
[22] Amato M,Veglia F,de Faire U,et al. Carotid plaque-thickness and common carotid IMT show additive value in cardiovascular risk prediction and reclassification[J]. Atherosclerosis,2017,263:412-419.
[23] Lee CJ,Park S. The role of carotid ultrasound for cardiovascular risk stratification beyond traditional risk factors[J]. Yonsei Med J,2014,55(3):551-557.
[24] Greenland P,Alpert JS,Beller GA,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol,2010,56(25):e50-e103.
[25] Polak JF,Pencina MJ,Pencina KM,et al. Carotid-wall intima-media thickness and cardiovascular events[J]. N Engl J Med,2011,365(3):213-221.
[26] Mantha S,Tripuraneni SL,Fleisher LA,et al. Use of common carotid intima-media thickness measured by ultrasound echo-tracking in cardiovascular risk stratification before noncardiac surgery in low-risk category:a research idea[J]. A A Pract,2020,14(5):166‐169.
[27] Gidding SS,Rana JS,Prendergast C,et al. Pathobiological Determinants of Atherosclerosis in Youth(PDAY) risk score in young adults predicts coronary artery and abdominal aorta calcium in middle age:the CARDIA Study[J]. Circulation,2016,133(2):139-146.
[28] Takayama Y,Yasuda Y,Suzuki S,et al. Relationship between abdominal aortic and coronary artery calcification as detected by computed tomography in chronic kidney disease patients[J]. Heart Vessels,2016,31(7):1030-1037.
[29] Andrus B,Lacaille D. 2013 ACC/AHA guideline on the assessment of cardiovascular risk[J]. J Am Coll Cardiol,2014,63(25 Pt A):2886.
[30] Laclaustra M,Casasnovas JA,Fernandez-Ortiz A,et al. Femoral and carotid subclinical atherosclerosis association with risk factors and coronary calcium:the AWHS study[J]. J Am Coll Cardiol,2016,67(11):1263-1274.
[31] Lin TC,Wright CM,Criqui MH,et al. Superior mesenteric artery calcification is associated with cardiovascular risk factors,systemic calcified atherosclerosis,and increased mortality[J]. J Vasc Surg,2018,67(5):1484-1490.
[32] Qin C,Zhang L,Wang X,et al. Evaluation of carotid plaque neovascularization in patients with coronary heart disease on contrast-enhanced ultrasonography[J]. J Ultrasound Med,2018,37(4):823-831.
[33] Tada H,Nakagawa T,Okada H,et al. Clinical impact of carotid plaque score rather than carotid intima-media thickness on recurrence of atherosclerotic cardiovascular disease events[J]. J Atheroscler Thromb,2020,27(1):38-46.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(8):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(8):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for
Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(8):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[4]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(8):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[5]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(8):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[6]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(8):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[7]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(8):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[8]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(8):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[9]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(8):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[10]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(8):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]